Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate

BACKGROUND: Infections affecting neonates caused by Staphylococcus aureus are widespread in healthcare facilities; hence, novel strategies are needed to fight this pathogen. In this study, we aimed to investigate the effectiveness of the FDA-approved medications ascorbic acid, dexamethasone, and sod...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Moustafa M., Yousef, Nehal, Shafik, Shokri M., Abbas, Hisham A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644464/
https://www.ncbi.nlm.nih.gov/pubmed/36348266
http://dx.doi.org/10.1186/s12866-022-02684-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644464/
https://www.ncbi.nlm.nih.gov/pubmed/36348266
http://dx.doi.org/10.1186/s12866-022-02684-x

Ejemplares similares